StockData
Vaccinex, Inc. logo

Vaccinex, Inc. (VCNX) stock

VCNXOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q4 năm tài chính 2024, quý kết thúc ngày Dec 31, 2024Last filing: 10-K on Apr 15, 2025
$1.00−0.01 (-0.99%)

Close on Oct 19, 2026Market cap $3.22MP/E –Yield –

Vaccinex price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Vaccinex's price to sales ratio was 4.5× on Oct 19, 2026, against 2.8× a year earlier. Over the last 5 years it ranged from 2.2× to 161.1×, with a median of 13.8×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Oct 19, 20264.5×−0.3
2025Dec 31, 20254.8×−1.8
2024Dec 31, 20246.6×+2.5
2023Dec 29, 20234.0×−41.1
2022Apr 29, 202245.2×+9.6
2021Dec 31, 202135.6×−68.3
2020Apr 30, 2020103.9×+26.2
2019Dec 31, 201977.7×–

More Vaccinex figures

See a number that looks wrong?